• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

CardiAQ Valve Technologies

edit

CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).

Milestones

edit

• 
  CardiAQ Valve Technologies added Rob Michiels as CEO.
  Posted 1/11/11 at 2:58am
• 
  CardiAQ Valve Technologies received $37.3M in Series B funding. (11/29/12)
  Posted 11/29/12 at 9:06pm via dowjones.com
• 
  CardiAQ Valve Technologies received $6.5M in Series A funding. (1/12/10)
  Posted 1/12/10 at 6:28pm via finsmes.com
• 
  CardiAQ Valve Technologies received $750k in Seed funding. (5/13/09)
  Posted 9/22/09 at 9:41pm via cardiaq.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/13/10

Sources

1. CardiAQ Valve Technologies (CVT) receives $750,000 'translational' funding from Broadview Ventures Inc (cardiaq.com) [edit]
2. CardiAQ Valve Technologies Closes $6.5M Series A Funding (finsmes.com) [edit]
3. CardiAQ Raises $37.3M Series B Led by OrbiMed (pevc.dowjones.com) [edit]